Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failure

Thyroid

Volumn 14, Issue 10, 2004, Pages 862-865

  Brusco, Francisca ^a   González, Gilberto ^a   Soto, Néstor ^b   Arteaga, Eugenio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PROPYLTHIOURACIL;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LIVER FAILURE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADULT; AMIODARONE; FEMALE; HUMANS; HYPERTHYROIDISM; LIVER FAILURE, ACUTE; PROPYLTHIOURACIL; TRIIODOTHYRONINE;

EID: 8444244056     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.862     Document Type: Review

References (30)

1. Cooper D 1999 Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, pp. 691-709.
2. Frenkel J, Téllez R, Reyes C, González G, Michaud P 1993 Major adverse reactions to propylthiouracil in 586 patients with hyperthyroidism. Rev Méd Chile 121:1289-1294.
3. Williams K, Nayak S, Becker D, Reyes J, Burmeister L 1997 Fifty years of experience with proplythiouracil associated hepatotoxicity: What have we learned? J Clin Endocrinol Metab 82:1727-1733.
4. Sheldom J 1983 Effects of amiodarone in thyrotoxicosis. Br J Med 286:267-268
5. Van Reeth O, Unger J 1991 Effects of amiodarone on serum T3 and T4 concentrations in hyperthyroid patients treated with propylthiouracil. Thyroid 1:301-306
6. Latini R, Tognoni G, Kates RE 1984 Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet 9:136-156.
7. Kennedy RL, Griffiths H, Gray TA 1989 Amiodarone and the thyroid. Clin Chem 35:1882-1887.
8. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the Thyroid. Endocr Rev 22:240-245.
9. Franklyn JA 1985 Amiodarone and thyroid hormone action. Clin Endocrinol 22:257-264.
10. O'Grady J, Schalm S, Williams R 1993 Acute liver failure: Redefining the syndromes. Lancet 342:273-275.
11. O'Grady J, Graeme A, Hayllar K, Williams R 1989 Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-445.
12. Kim HJ, Kim BH, Han YS, Yang I, Kim KJ, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R 2001 The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: A single-center retrospective study. Am J Gastroenterol 96:165-169.
13. Ruiz J, Rossi G, Vallejos H, Brenet R, López I, Escribano A 2003 Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother 37:224-228.
14. Huang M, Li K, Wu S, Fan K, Liaw Y 1994 Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol 89:1071-1076.
15. Oren R, Dotan I, Papa M, Marravi Y, Aeed H, Barg J, Zeidel L, Bruck R, Halpern Z 1996 Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. Hepatology 24:419-423.
16. Bruck R, Oren R, Shirin H, Aeed H, Papa M, Matas Z, Zaidel L, Avni Y, Halpern Z 1998 Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure. Hepatology 27:1013-1020.
17. Shirin H, Oren R, Dotan I, Papa M, Maaravi Y, Aeed H, Zaidel L, Matas Z, Bruck R, Halpern Z 1995 Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism. J Hepatol 23:213A.
18. Bruck R, Frenkel D, Shirin H, Aeed H, Matas Z, Papa M, Zaidel L, Avni Y, Oren R, Halpern Z 1999 Hypothyroidism protects rat liver from acetaminophen hepatotoxicity. Dig Dis Sci 44:1228-1235.
19. Arteaga E, López J, Rodríguez J, Michaud P, López G 1983 Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Grave's disease. Clin Endocr 19:619-627.
20. De Groot L, Hoye K 1976 Dexamethasone suppression of serum T3 and T4. J Clin Endocrinol Metab 42:976-978.
21. Weiss M, Hassin D, Bank H 1980 Propylthiouracil-induced hepatic damage. Arch Intern Med 140:1184-1185.
22. Waseem M, Seshadri KG, Kabadi UM 1998 Successful outcome with methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity. Endocr Pract 4:197-200.
23. Philippou G, Koutras D, Piperingos G, Souvatzoglou A, Moulopoulos SD 1992 The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol 36:573.
24. Emerson C, Anderson A, Howard W, Utiger RD 1975 Serum thyroxine and triiodothyronine concentration during iodide treatment of hyperthyroidism J Clin Endocrinol Metab 40:33-36.
25. Braga M, Cooper D 2001 Oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab 86:1853-1860.
26. Wang Y, Tsou C, Lin W, Hershman J 1987 Long term treatment of Grave's disease with Iopanoic acid (Telepaque). J Clin Endocrinol Metab 65:679-682.
27. Martino E, Balzano S, Bartalena L, Louiselli A, Sica V, Petrini L, Grasso L, Piga M, Braverman LE 1991 Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. J Endocrinol Invest 14:847-851.
28. Burger A, Dinichert D, Nicod P, Jenny M, LeMarchand-Béraud T, Vallotton M 1976 Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. J Clin Invest 58:255-259.
29. Gregory S, Webster J, Chapman G 2002 Acute hepatitis induced by parenteral amiodarone. Am J Med 113:254-255.
30. Martino E, Aghini-Lombardi F, Lippi F, Baschieri L, Safran M, Braverman L, Pinchera A 1985 Twenty-four hour RAIU in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med 26:1402-1407.